Home › Funds › BOONE CAPITAL MANAGEMENT LLC › KYMR
BOONE CAPITAL MANAGEMENT LLC position in KYMR
KYMERA THERAPEUTICS INC · Health Care
BOONE CAPITAL MANAGEMENT LLC reported holding 113,173 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$13.0M, representing 3.04% of its reported portfolio and ranking #14 among its reported holdings. BOONE CAPITAL MANAGEMENT LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BOONE CAPITAL MANAGEMENT LLC's KYMR position evolved
BOONE CAPITAL MANAGEMENT LLC first disclosed a stake in KYMR in Q2 2026 at 113,173 shares (US$13.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 113.17K | $12.98M | New |
About KYMR and 13F data
KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KYMR
- BAKER BROS. ADVISORS LP 8.66M sh · $992.73M · Q2 2026
- Avoro Capital Advisors LLC 7.47M sh · $857.13M · Q2 2026
- T. Rowe Price Investment Management, Inc. 6.26M sh · $717.52M · Q2 2026
- BVF INC/IL 3.87M sh · $444.01M · Q2 2026
- Siren, L.L.C. 2.94M sh · $336.65M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.85M sh · $326.53M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 919.23K sh · $105.41M · Q2 2026
- Merck & Co., Inc. 772.16K sh · $88.54M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 740.87K sh · $84.96M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 504.21K sh · $57.81M · Q2 2026
- Rock Springs Capital Management LP 453.16K sh · $51.96M · Q2 2026
- Boxer Capital Management, LLC 429.10K sh · $49.20M · Q2 2026
More on BOONE CAPITAL MANAGEMENT LLC
FAQ
How long has BOONE CAPITAL MANAGEMENT LLC held KYMR?
BOONE CAPITAL MANAGEMENT LLC has disclosed KYMR holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is BOONE CAPITAL MANAGEMENT LLC's current position in KYMR?
As of Q2 2026, BOONE CAPITAL MANAGEMENT LLC holds 113.17K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $12.98M, representing 3.04% of its reported portfolio and ranking #14.
Has BOONE CAPITAL MANAGEMENT LLC been buying or selling KYMR?
In the latest 13F filing (Q2 2026), BOONE CAPITAL MANAGEMENT LLC newly opened its position in KYMR.
Which other funds hold KYMR?
Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.